01-07-2022 | Urothelial Cancer | Case report
Enfortumab-vedotin
Toxic epidermal necrolysis and compassionate use: case report
Published in: Reactions Weekly | Issue 1/2022
Login to get accessExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event